Support for Electronic Health Information Varies With Use

Share this content:
Support for Electronic Health Information Varies With Use
Support for Electronic Health Information Varies With Use

(HealthDay News) -- Consent and purpose are important for public support of secondary uses of electronic health information, according to a study published in the Dec. 16 issue of the Annals of Internal Medicine.

David Grande, M.D., M.P.A., from the University of Pennsylvania in Philadelphia, and colleagues conducted a nationally representative survey involving 3,064 African-American, Hispanic, and non-Hispanic whites to examine public support for secondary uses of electronic health information under different consent arrangements. The perceptions of uses of electronic health information were assessed according to patient consent, use (research versus marketing), and framing of the findings (abstract description versus specific results).

The researchers found that the mean ratings of appropriateness of health information use varied from a low of 3.81 for marketing use when consent was not obtained and specific results were presented to a high of 7.06 for research use when consent was obtained and specific results were presented. Scenarios in which consent was obtained were rated as more appropriate than those in which consent was not obtained (difference, 1.01; P < 0.001). Scenarios in which the use was marketing were rated as less appropriate than those in which the use was research (difference, −2.03; P < 0.001). The respondents rated unconsented research as more appropriate than consented marketing (difference, 1.13).

"Although approaches to health information sharing emphasize consent, public opinion also emphasizes purpose, which suggests a need to focus more attention on the social value of information use," the authors write.

Full Text (subscription or payment may be required)
Ideas and Opinions (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »